Ipsos SA
XMUN:IPZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ipsos SA
XMUN:IPZ
|
FR |
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
|
O
|
Organon & Co
XMUN:7XP
|
US |
|
Tokyo Metro Co Ltd
F:XO7
|
JP |
Wall St Price Targets
IPZ Price Targets Summary
Ipsos SA
According to Wall Street analysts, the average 1-year price target for IPZ is 56.17 EUR with a low forecast of 37.44 EUR and a high forecast of 77.42 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IPZ's stock price target?
Price Target
56.17
EUR
According to Wall Street analysts, the average 1-year price target for IPZ is 56.17 EUR with a low forecast of 37.44 EUR and a high forecast of 77.42 EUR.
What is the Revenue forecast for Ipsos SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Ipsos SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Ipsos SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 12%.
